The global portable oxygen concentrators market size was valued at USD 1.9 Billion in 2024, and it is expected to reach USD 3.5 Billion by 2033, exhibiting a growth rate (CAGR) of 6.97% from 2025 to 2033.
To get more information on this market, Request Sample
The increasing incidence of respiratory diseases such as chronic obstructive pulmonary disease, asthma, and sleep apnea requires efficient oxygen therapy products, which is fueling the demand for portable oxygen concentrators. Moreover, the increasing elderly population vulnerable to respiratory disorders further expands the market potential. Air pollution and rising number of smokers worldwide further deteriorate respiratory conditions, thus driving the demand for portable oxygen therapy products.
The portable oxygen concentrator technology has also seen advancements with regards to increased efficiency with longer battery life and reduced and lighter designs that increase user appeal for mobility and independence while receiving treatment. Market trends reflect increased preference toward home-based care solutions since they are cost-effective and convenient as opposed to a hospital stay. This has influenced the manufacturers innovate POCs to cater to patient-specific needs. Further, better healthcare infrastructure and awareness programs on oxygen therapy are the drivers that are enhancing the adoption of portable devices in the emerging market. Integration of smart technologies, including connectivity to mobile applications for remote monitoring and adjustment, is also picking up with the increased adoption of digital health tools. Besides, in developed countries, government initiatives in terms of subsidies and reimbursements for medical devices are also expanding access to the market.
The market research report provides a comprehensive analysis of all the major regions, including North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. North America is reported to hold a major portion of the revenue share in the market. Due to increased rates of respiratory diseases like COPD and asthma caused by demographic and environmental conditions, the market is witnessing growth. Additionally, it is due to enhanced expenditure on healthcare services along with patient preference towards care within homes as portables would enhance their convenience and mobility with regard to oxygen therapy.
North America is a key regional market for portable oxygen concentrators. Technological innovations including lightweight designs, extra-long battery life, and smart features like app connectivity are molding the market trends. Further, the government policies supporting Medicare reimbursement have widened access to these devices. With the value-based care model and personalized treatment, more patients need such advanced, user-oriented concentrators. Higher consciousness toward respiratory health and increasing desire for a better quality of patients' lives are also positive contributors to the market.
The Asia Pacific portable oxygen concentrator market is expanding significantly as a result of rising healthcare costs and the high incidence of respiratory illnesses. Malaysia and Thailand are now increasingly witnessing medical tourism, thereby increasing the demand for portable oxygen concentrators. Tie-ups between global companies and local distributors also ensure that the product reaches more consumers.
High prevalence of chronic respiratory conditions and a growing elderly population in Europe drive the European portable oxygen concentrators market. Awareness among patients regarding early diagnosis and oxygen therapy boosts adoption. Favorable reimbursement policies also support market growth across countries like Germany, France, and the UK. Increased focus on home-based care solutions and improved technology in medical devices is also contributing to demand in the region.
The market for portable oxygen concentrators in Latin America is growing with increasing respiratory diseases, such as COPD and asthma, due to pollution and rising smoking rates. With an improvement in the accessibility and affordability of healthcare services, such as in Brazil and Mexico, the demand for high-tech medical equipment has increased. With more awareness campaigns and increasing acceptance of homecare oxygen therapy, these factors are becoming crucial. Moreover, investments in healthcare infrastructure and the growing availability of compact, cost-effective portable concentrators are further propelling market growth in the region.
The portable oxygen concentrators market in the Middle East and Africa is gaining traction due to an increase in cases of chronic respiratory diseases and home healthcare solution adoption. Urbanization coupled with high levels of pollution have resulted in more respiratory-related diseases, especially within the urban regions of the GCC countries and South Africa. Besides, growing medical tourism and significant investments in advanced healthcare facilities are likely to contribute to growth in this market in this region.
Some of the key companies in the global portable oxygen concentrators market include Caire Inc. (NGK Spark Plug Co. Ltd), Chart Industries Inc., Drive Devilbiss Healthcare Limited (Drive International LLC), Inogen Inc., Invacare Corporation, Koninklijke Philips N.V., Nidek Medical India Pvt Ltd, O2 Concepts LLC, Precision Medical Inc. (BioHorizons Inc.), Resmed Inc., Teijin Limited among others. Leading players in the market are engaging in strategic partnerships and product innovation to enhance their offerings and expand their market presence. For instance, in October 2024, Inogen Inc. announced the introduction of the Rove 4 Portable Oxygen Concentrator, which features a fourth flow setting that delivers 840ml/min of oxygen and offers up to 5.75 hours of operation in a portable design that enhances ambulatory oxygen therapy for patients.
Report Features | Details |
---|---|
Market Size in 2024 | USD 1.9 Billion |
Market Forecast in 2033 | USD 3.5 Billion |
Market Growth Rate 2025-2033 | 6.97% |
Units | Billion USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Technologies Covered | Continuous Flow, Pulse Flow |
Applications Covered | Chronic Obstructive Pulmonary Disease (COPD), Asthma, Respiratory Distress Syndrome, Sleep Apnea, others |
End Uses Covered | Hospitals, Ambulatory surgery Centers, Others |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Caire Inc. (NGK Spark Plug Co. Ltd), Chart Industries Inc., Drive Devilbiss Healthcare Limited (Drive International LLC), Inogen Inc., Invacare Corporation, Koninklijke Philips N.V., Nidek Medical India Pvt Ltd, O2 Concepts LLC, Precision Medical Inc. (BioHorizons Inc.), Resmed Inc. and Teijin Limited |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |